Quick Summary

Wegovy vs Zepbound costs depend on your insurance plan, not on list prices, since neither drug has one insured price for everyone. GoodRx reported in 2026 that 9% of commercially insured people had unrestricted Wegovy coverage, versus 4% for Zepbound. Check your plan’s formulary and prior authorization rules before comparing.

  • Only 9% of commercially insured people had unrestricted Wegovy coverage in 2026.
  • Only 4% of commercially insured people had unrestricted Zepbound coverage as of July 2026.
  • List prices are the manufacturer’s pre-insurance price, not what most insured patients pay.
  • Ask whether a quoted copay assumes your deductible is already met.
  • Confirm the drug is covered for weight management, not only for another indication.

Table of Contents

Wegovy vs Zepbound Cost With Insurance: The Short Answer

Last Updated: November 11, 2026

When comparing wegovy vs zepbound, their costs can differ widely depending on your insurance plan, and neither medication has a single “insured price” that applies to everyone. GoodRx reported in 2026 that only 9% of people with commercial insurance had unrestricted coverage for Wegovy, compared with 4% for Zepbound GoodRx weight-loss medication fill and coverage tracker. That gap means the real question is less “which costs less” and more “will my plan cover it at all, and on what terms.”

At MedShape Weight Loss Clinics, we see patients ask this comparison every week. The honest answer is that the list price comparison, which puts Wegovy at just under $1,350 a month and Zepbound at just over $1,000, is only a starting point Noom’s published cost comparison. Your out-of-pocket cost depends on your plan’s formulary, prior authorization rules and deductible.

Because coverage is so plan-specific, a fair comparison has to be run for your own insurance. Below, we explain why list prices mislead, what coverage looks like for each medication, and how to verify your numbers before you commit.

Why List Prices Don’t Tell You What You’ll Pay

List price is what the manufacturer sets before any insurance discount, rebate or negotiated rate is applied. It is not the amount most insured patients pay at the pharmacy counter.

Researchers at the University of Chicago estimated monthly prices of $700 for Wegovy and $520 for Zepbound, figures far below the list prices most people see online New York Times coverage of University of Chicago researchers’ price estimates. Those are estimates, not what any individual insured patient will be charged.

Insurance changes the math in both directions. A plan may cover the drug with a modest copay, or it may exclude weight-loss use entirely. Many plans also require prior authorization. GoodRx notes that some people will not have coverage at all for either medication, which is why checking your specific plan matters more than comparing advertised prices GoodRx coverage update on weight-loss medications.

Wegovy Insurance Coverage for Weight Loss

Wegovy is FDA-approved for chronic weight management in adults with obesity, or with overweight plus at least one weight-related condition. That approval does not guarantee insurance coverage. Plans decide separately whether to cover it for weight loss.

Coverage is more common than for Zepbound in the data available to us. GoodRx reported unrestricted commercial coverage of 9% for Wegovy in 2026 GoodRx weight-loss medication fill tracker. Even so, most covered patients still face prior authorization or coverage criteria.

Manufacturer support can reduce costs for eligible commercially insured patients. Support programs such as NovoCare publish eligibility rules tied to specific plans, so confirm your eligibility before assuming a savings card applies.

Zepbound Insurance Coverage for Weight Loss

Zepbound, a once-weekly injection, has seen narrower unrestricted coverage. GoodRx reported that 4% of people with commercial insurance had unrestricted coverage for Zepbound as of July 2026, down from 5% GoodRx 2026 coverage tracker.

That narrower coverage is the main reason patients ask about cash and savings options for Zepbound. Manufacturer savings programs may reduce costs for commercially insured patients whose plans cover the drug, but they do not create coverage where a plan excludes it.

For patients weighing options, a practical step is to compare the insured out-of-pocket estimate for each medication side by side, not the list prices.

Estimating Your Insured Cost by Plan Type

A list price tells you what the manufacturer charges before insurance. An insured cost estimate tells you what you will actually pay, and that number is built from four moving parts: your deductible, your copay or coinsurance, your plan’s pharmacy tier, and whether prior authorization is required. Run the same four-part calculation for Wegovy and for Zepbound, and the comparison becomes concrete instead of theoretical.

Start with the formula most plans use. If you are still in the deductible phase, you generally pay the full negotiated rate until the deductible is met. After the deductible, you pay either a flat copay (for example, a tier 2 or tier 3 copay) or a coinsurance percentage of the negotiated rate. Your share depends on your plan’s coinsurance or copay structure and the negotiated rate, which is why two patients on the same drug can report very different monthly costs. Review a detailed insured cost breakdown by coverage and pricing to compare against your own numbers.

A practical way to estimate annual out-of-pocket spending is to multiply the post-deductible monthly cost by the number of fills per year, then add the amount you pay to satisfy the deductible. Learn how to check if your insurance covers Zepbound step by step. Your plan documents control your actual first-year estimate, which combines your deductible with your post-deductible cost-sharing.

How the plan type changes the math:

  • Employer-sponsored commercial plan: The formulary tier drives much of the cost. Check whether the plan applies a separate deductible for pharmacy benefits and whether weight-management drugs are excluded by rider.
  • Marketplace or individual plan: Formularies and tier placements can change at each plan year, and the same drug may move tiers between bronze and silver plans. Confirm the current formulary before you enroll or renew, and check whether the plan requires step therapy before approving either drug.
  • Medicare Part D: Weight-loss use has historically been excluded, though a federal pilot has offered eligible Part D participants access to Wegovy and Zepbound KwikPens for $50 per month Healthline report on the Medicare GLP-1 pilot. Outside that pilot, check Medicare.gov for current eligibility and any Part D formulary changes.
  • Medicaid: Coverage is set state by state, so contact your state Medicaid office for current rules. Contact your state Medicaid office for the current preferred drug list.

Watch out: a quoted monthly copay from a pharmacy benefit representative often assumes the deductible is already met. Ask specifically whether the quote is pre-deductible or post-deductible, and whether it includes a manufacturer savings card, otherwise your first fill can cost several times the quoted amount.

Manufacturer savings programs may reduce costs for some eligible commercially insured patients. Confirm the current terms with the manufacturer. Build your estimate without the card first, then subtract the card benefit only if you confirm eligibility. That gives you a realistic annual number for Wegovy and for Zepbound side by side, rather than a single monthly price that may not survive the first fill.

The table below lays out how the main plan types affect what you pay, using the points the section makes.

Plan type What drives your cost What to check first
Employer-sponsored commercial Formulary tier and pharmacy deductible Whether weight-management drugs are excluded by rider
Marketplace or individual Tier placement, changes each plan year Current formulary and step therapy rules
Medicare Part D Weight-loss use historically excluded Medicare.gov eligibility and Part D formulary
Medicaid Set state by state Your state Medicaid preferred drug list

How to Verify Coverage and Appeal a Denial

Most insured patients lose money not because their plan refuses to cover Wegovy or Zepbound, but because they never confirm the plan’s exact rules before the first fill. A step-by-step verification process takes about 30 minutes and prevents most surprise bills.

Step-by-step infographic for verifying insurance coverage and appealing denials for Wegovy vs Zepbound medications
Step-by-step infographic for verifying insurance coverage and appealing denials for Wegovy vs Zepbound medications

Step 1: Pull the formulary, not the marketing page. Log into your insurer’s member portal and download the current pharmacy formulary PDF. Search for both brand names and the generic names (semaglutide for Wegovy, tirzepatide for Zepbound). Note the tier, any quantity limit, and whether the entry says “PA” (prior authorization), “ST” (step therapy), or “QL” (quantity limit).

Step 2: Confirm the weight-management benefit. A drug can be on the formulary and still be excluded when prescribed for chronic weight management rather than for another FDA-approved indication. Ask the representative to confirm coverage under the specific diagnosis your prescriber will submit. Coverage for weight loss and coverage for a different indication are separate questions, and the answer can differ for the same drug on the same plan.

Step 3: Get the prior-authorization criteria in writing. Ask the insurer to send the clinical criteria for approval, typically body mass index thresholds, a requirement for a documented weight-related condition, and evidence of a prior program. Your prescriber needs those criteria to submit a complete authorization. A common pattern is denial for an incomplete packet rather than for medical necessity.

Step 4: Confirm the exact pharmacy price for the exact dose. Wegovy and Zepbound are dose-escalation drugs, and the price can change as the dose changes. Ask the pharmacy for the price of the specific dose on your prescription, and ask whether the quote assumes the deductible is met and whether it includes a savings card.

Step 5: If you are denied, request the reason in writing. Get current guidance on how shortages affect access and what to do next. Ask for a written denial that states the specific reason and the appeal instructions, and note the appeal deadline.

Step 6: File the internal appeal with clinical documentation. Work with your prescriber to submit chart notes, prior weight-management attempts, and any relevant lab work that addresses the insurer’s stated criteria. Address the denial reason directly rather than resubmitting the same packet.

Step 7: Escalate to external review if the internal appeal fails. For employer-sponsored plans, the Department of Labor explains external review rights that may apply after an internal appeal is exhausted Department of Labor on group health plan appeals. For Medicare and Medicaid members, the Centers for Medicare & Medicaid Services publishes appeal rights and timelines CMS guidance on coverage appeals.

Watch out: a denial based on a missing prior authorization is often fixable, but a denial based on a plan exclusion for weight-management drugs usually is not, in that case, the realistic paths are a formulary exception request, a different plan at open enrollment, or a cash-pay or savings-program option. Knowing which type of denial you received saves weeks of appeals that cannot succeed.

Keep a written log of every call: date, representative name, reference number, and what you were told. If a representative gives you a coverage answer that later turns out to be wrong, that log is the basis for an expedited review.

Booking a Coverage Review at MedShape

If you want help estimating your insured cost, MedShape Weight Loss Clinics offers medically supervised programs, including compounded Tirzepatide and Semaglutide options. Our team can review your goals and discuss which approach fits your situation. Book a coverage review with the clinic to get started. Pricing depends on your treatment plan, so contact us directly for a current quote.

Frequently Asked Questions

Is Wegovy or Zepbound cheaper with insurance?

Neither is automatically cheaper. Coverage depends on your specific plan, its formulary, and whether it requires prior authorization. Some commercial plans exclude weight-loss use entirely, while others cover one drug and not the other. The only reliable answer comes from your plan’s formulary and your pharmacy’s quoted copay. Ask your insurer directly which product is covered for weight management and what your out-of-pocket amount would be for each.

How much does Wegovy cost with insurance?

Costs with insurance vary widely. Manufacturer savings programs may reduce the out-of-pocket cost for eligible commercial plan members. Confirm current terms with the manufacturer. Your actual cost depends on plan design, deductible status, and whether weight-loss coverage is included at all. Confirm with your plan and pharmacy before assuming any figure applies to you.

Do Wegovy and Zepbound require prior authorization?

Many plans require prior authorization for both medications, and criteria often include documented BMI, weight-related conditions, and prior attempts at lifestyle changes. Requirements differ by insurer and plan year. Your prescriber can submit the request, and if it is denied, you can ask for the specific coverage criteria in writing and file an appeal. Keep copies of all correspondence.

Can I use a manufacturer savings card with insurance?

Savings cards are generally available only to patients with eligible commercial insurance and are not valid under government programs such as Medicare or Medicaid. Eligibility rules, enrollment periods, and annual maximums change, so check the current terms on the manufacturer’s site. A savings card works alongside your insurance; it does not replace coverage.